Differential actions of eplerenone and spironolactone on the protective effect of testosterone against cardiomyocyte apoptosis in vitro;Efecto diferencial de espironolactona frente a eplerenona sobre el papel protector in vitro de testosterona en la apoptosis de cardiocitos

Revista Espanola de Cardiologia

Volumn 63, Issue 7, 2010, Pages 779-787

  Sánchez Más, Jesús ^a   Turpín, María C ^a   Lax, Antonio ^a   Ruipérez, Juan A ^a   Valdés Chávarri, Mariano ^a   Pascual Figal, Domingo A ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

Author keywords

Aldosterone antagonists; Apoptosis; Heart cell line; Testosterone

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; DNA; EPLERENONE; FLUTAMIDE; MITOGEN ACTIVATED PROTEIN KINASE; SORBITOL; SPIRONOLACTONE; TESTOSTERONE; MINERALOCORTICOID ANTAGONIST;

ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL LINE; CELL PROTECTION; CELL VIABILITY; DNA FRAGMENTATION; DRUG EXPOSURE; DRUG MECHANISM; ENZYME ACTIVATION; HEART MUSCLE CELL; HYPEROSMOTIC STRESS; IN VITRO STUDY; NONHUMAN; PROGNOSIS; RAT; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; ANIMAL; CELL SURVIVAL; COMPARATIVE STUDY; DRUG EFFECTS; DRUG POTENTIATION;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE; CELL SURVIVAL; DNA FRAGMENTATION; DRUG SYNERGISM; MINERALOCORTICOID RECEPTOR ANTAGONISTS; MYOCYTES, CARDIAC; RATS; SPIRONOLACTONE; TESTOSTERONE;

EID: 77954960931     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/S0300-8932(10)70180-9     Document Type: Article

References (29)

1. P.M. Kang, and S. Izumo Apoptosis and heart failure: A critical review of the literature Circ Res 86 2000 1107 1113
2. C.J. Malkin, P.J. Pugh, R.D. Jones, D. Kapoor, K.S. Channer, and T.H. Jones The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men J Clin Endocrinol Metab 89 2004 3313 3318
3. E.A. Jankowska, B. Biel, J. Majda, A. Szklarska, M. Lopuszanska, and M. Medras Anabolic deficiency in men with chronic heart failure: prevalence and detrimental impact on survival Circulation 114 2006 1829 1837
4. D.A. Pascual-Figal, P.L. Tornel, and M. Valdes Letter by Pascual-Figal et al regarding article, "Anabolic deficiency in men with chronic heart failure: prevalence and detrimental impact on survival" Circulation 115 2007 e548
5. C. Maldonado, P. Cea, T. Adasme, A. Collao, G. Diaz-Araya, and M. Chiong IGF-1 protects cardiac myocytes from hyperosmotic stress-induced apoptosis via CREB Biochem Biophys Res Commun 336 2005 1112 1118
6. M. Estrada, A. Espinosa, M. Muller, and E. Jaimovich Testosterone stimulates intracellular calcium release and mitogen-activated protein kinases via a G protein-coupled receptor in skeletal muscle cells Endocrinology 144 2003 3586 3597
7. T.V. Nguyen, M. Yao, and C.J. Pike Androgens activate mitogenactivated protein kinase signaling: role in neuroprotection J Neurochem 94 2005 1639 1651
8. P.J. Pugh, K.M. English, T.H. Jones, and K.S. Channer Testosterone: a natural tonic for the failing heart? QJM 93 2000 689 694
9. B. Pitt, F. Zannad, W.J. Remme, R. Cody, A. Castaigne, and A. Perez The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators N Engl J Med 341 1999 709 717
10. B. Pitt, M. Gheorghiade, F. Zannad, J.L. Anderson, D.J. Van Veldhuisen, and A. Parkhomenko Evaluation of eplerenone in the subgroup of EPHESUS patients with baseline left ventricular ejection fraction
11. M. De Gasparo, U. Joss, H.P. Ramjoue, S.E. Whitebread, H. Haenni, and L. Schenkel Three new epoxy-spirolactone derivatives: characterization in vivo and in vitro J Pharmacol Exp Ther 240 1987 650 656
12. G.D. Charles, H.L. Kan, M.R. Schisler, G.B. Bhaskar, and M.M. Sue A comparison of in vitro and in vivo EDSTAC test battery results for detecting antiandrogenic activity Toxicol Appl Pharmacol 202 2005 108 120
13. H. Kohno, N. Takahashi, T. Shinohara, T. Ooie, K. Yufu, and M. Nakagawa Receptor-mediated suppression of cardiac heat-shock protein 72 expression by testosterone in male rat heart Endocrinology 148 2007 3148 3155
14. A.R. Wright, and S.A. Rees Cardiac cell volume: crystal clear or murky waters? A comparison with other cell types Pharmacol Ther 80 1998 89 121
15. A. Gálvez, M.P. Morales, J.M. Eltit, P. Ocaranza, L. Carrasco, and X. Campos A rapid and strong apoptotic process is triggered by hyperosmotic stress in cultured rat cardiac myocytes Cell Tissue Res 304 2001 279 285
16. J. Reid, R. Betney, K. Watt, and I.J. McEwan The androgen receptor transactivation domain: the interplay between protein conformation and protein-protein interactions Biochem Soc Trans 31 2003 1042 1046
17. F. Er, G. Michels, N. Gassanov, F. Rivero, and U.C. Hoppe Testosterone induces cytoprotection by activating ATP-sensitive K+ channels in the cardiac mitochondrial inner membrane Circulation 110 2004 3100 3107
18. J.M. Vicencio, C. Ibarra, M. Estrada, M. Chiong, D. Soto, and V. Parra Testosterone induces an intracellular calcium increase by a nongenomic mechanism in cultured rat cardiac myocytes Endocrinology 147 2006 1386 1395
19. T. Tanaka, M. Nangaku, T. Miyata, R. Inagi, T. Ohse, and J.R. Ingelfinger Blockade of calcium influx through L-type calcium channels attenuates mitochondrial injury and apoptosis in hypoxic renal tubular cells J Am Soc Nephrol 15 2004 2320 2333
20. J.L. Scragg, M.L. Dallas, and C. Peers Molecular requirements for L-type Ca2+ channel blockade by testosterone Cell Calcium 42 2007 11 15
21. D.K. Bowles, K.K. Maddali, V.C. Dhulipala, and D.H. Korzick PKCdelta mediates anti-proliferative, pro-apoptic effects of testosterone on coronary smooth muscle Am J Physiol Cell Physiol 293 2007 C805 C813
22. I.R. Reid, D.J. Wattie, M.C. Evans, and J.P. Stapleton Testosterone therapy in glucocorticoid-treated men Arch Intern Med 156 1996 1173 1177
23. K. Dickstein, A. Cohen-Solal, G. Filippatos, J. McMurray, P. Ponikowski, and P.A. Poole-Wilson Guía de práctica clínica de la Sociedad Europea de Cardiología (ESC) para el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica (2008) Rev Esp Cardiol 61 2008 1329.e1-e70
24. R.M. Losel, E. Falkenstein, M. Feuring, A. Schultz, H.C. Tillmann, and K. Rossol-Haseroth Nongenomic steroid action: controversies, questions, and answers Physiol Rev 83 2003 965 1016
25. E.V. Younglai, Y.J. Wu, T.K. Kwan, and C.Y. Kwan Non-genomic action of estradiol and progesterone on cytosolic calcium concentrations in primary cultures of human granulosa-lutein cells Hum Reprod 20 2005 2383 2390
26. S.M. Aronica, W.L. Kraus, and B.S. Katzenellenbogen Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription Proc Natl Acad Sci U S A 91 1994 8517 8521
27. Y. Zhu, C.D. Rice, Y. Pang, M. Pace, and P. Thomas Cloning, expression, and characterization of a membrane progestin receptor and evidence it is an intermediary in meiotic maturation of fish oocytes Proc Natl Acad Sci U S A 100 2003 2231 2236
28. J.C. Barbato, P.J. Mulrow, J.I. Shapiro, and R. Franco-Sáenz Rapid effects of aldosterone and spironolactone in the isolated working rat heart Hypertension 40 2002 130 135
29. P. Aukrust, T. Ueland, L. Gullestad, and A. Yndestad Testosterona: A novel therapeutic approach in chronic heart failure J Am Coll Cardiol 54 2009 928 929